✦ LIBER ✦

A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration

✍ Scribed by Marc Dorval; François Madore; Sylvie Courteau; Martine Leblanc

Publisher: Springer
Year: 2003
Tongue: English
Weight: 218 KB
Volume: 29
Category: Article
ISSN: 1432-1238
DOI: 10.1007/s00134-003-1801-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anticoagulant regimens in acute continuo

Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study

✍ R. Bellomo; H. Teede; N. Boyce 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 483 KB

Citrate vs. heparin for anticoagulation

Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study

✍ Mehran Monchi; Denis Berghmans; Didier Ledoux; Jean-Luc Canivet; Bernard Dubois; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 139 KB

Ethylenediaminetetraacetic acid plus cit

Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): A novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood

✍ Macey, Marion ;McCarthy, Desmond ;Azam, Urooj ;Milne, Timothy ;Golledge, Peter ; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

## Abstract Ethylenediaminetetraacetic acid (EDTA) is the anticoagulant recommended for full blood counts, citrate is recommended for coagulation and platelet studies, and citrate‐theophylline‐adenosine‐dipyridamole (CTAD) inhibits platelet activation. Because the combination of EDTA and CTAD (E/C)